Skip to content

China Cohort Study of Rheumatoid Arthritis

China Cohort Study of Rheumatoid Arthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2022000044
Enrollment
Unknown
Registered
2022-07-05
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid arthritis

Interventions

No grouping:No restrictions were set on medication interventions

Sponsors

Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: ?meet the 1987 American College of Rheumatology (ACR) revised classification criteria for RA; ?Chinese residents aged >18 years; and ?agree to sign the informed consent form.

Exclusion criteria

Exclusion criteria: ?Patients with cognitive or other impairments (e.g., visual acuity, etc.) that affect the participant's ability to complete the self-report; ?Patients with severe combined diseases of vital organs such as cardiovascular, cerebral, hepatic, pulmonary, renal and hematopoietic systems, acute and chronic infectious diseases, malignancies, and psychiatric diseases; ?Patients with autoimmune diseases other than overlapping RA

Design outcomes

Primary

MeasureTime frame
Patient-based Clinical Reported Outcome Scale;

Secondary

MeasureTime frame
HAQ scale;VAS scale;Rheumatoid arthritis Chinese medical evidence efficacy evaluation scale;Tongue image information;Indicators of inflammation in the acute phase;Mean disease activity score for 28 joints;

Countries

China

Contacts

Public Contacthanman

Guang'anmen Hospital, Chinese Academy of Traditional Chinese Medicine

hanman111@126.com15011565229

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026